Method of Treating Chronic Myeloid Leukemia Using Pegylated Interferon and Tyrosine Kinase Inhibitor

Described herein is a method of treating chronic myeloid leukemia in a subject including administering to a subject in need thereof a pegylated interferon-a and a BCR-ABL tyrosine kinase inhibitor simultaneously or sequentially.

Saved in:
Bibliographic Details
Main Author Lin, Ko-Chung
Format Patent
LanguageEnglish
Published 06.04.2023
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Described herein is a method of treating chronic myeloid leukemia in a subject including administering to a subject in need thereof a pegylated interferon-a and a BCR-ABL tyrosine kinase inhibitor simultaneously or sequentially.
Bibliography:Application Number: AU20220211867